AbbVie sues HHS over 340B patient definition
Ella Jeffries / beckershospitalreview - AbbVie has filed a lawsuit challenging federal guidance on how “patient” is defined under the 340B program, according to an April 8 press release. The company said the current definition, based on guidance issued in 1996, allows covered entities to claim …
AI Summary: AbbVie has filed suit challenging HHS’s interpretation of the 340B program, arguing the agency’s “patient” definition and related guidance are outdated and legally flawed. The company seeks judicial clarity that could reshape who qualifies for discounted drugs and how hospitals and manufacturers navigate the program — yes, the pricing drama continues.
Related Stories
340B discounts face reform as profits outpace patient benefit / 2 months
Thousands of Medicare beneficiaries unexpectedly lose 'free' drug plans / 11 hrs
Bill would let patient drug spending count toward insurance deductibles / 2 months
Tampa General sues Eli Lilly over pulled 340B discounts / 11 hrs
Hospitals push regulators to block expanded 340B claims reporting requirements / 4 months
Hospitals protest as Eli Lilly withholds 340B drug discounts nationwide / 18 days
UnitedHealth proposes FTC settlement over insulin rebates and pricing / 28 days
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Cancer Screening, Long COVID, Price Transparency, Government Policy and look for the RSS link.
StackHealth Time Machine